Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
Clinical trial NCT01313221 · COMPLETED
Trial details
- NCT number
- NCT01313221
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2012-12-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.